dexpramipexole

Knopp’s oral asthma drug hits primary endpoint in phase 2
Fierce Biotech
Thu, 01/14/21 - 10:37 am
Knopp Biosciences
clinical trials
dexpramipexole
eosinophilic asthma
Knopp Biosciences' Dexpramipexole Meets Primary Endpoints in Phase 2 Trial Results in Hypereosinophilic Syndromes (HES)
CP Wire
Thu, 05/10/18 - 10:08 am
Knopp Biosciences
dexpramipexole
hypereosinophilic syndromes
Knopp Biosciences' Dexpramipexole Meets Primary Endpoints in Phase 2 Trial Results in Hypereosinophilic Syndromes (HES)
Thu, 05/10/18 - 10:09 am
Knopp Biosciences
dexpramipexole
hypereosinophilic syndromes
Biogen Idec Retools After ALS Drug Trial Failure
Seeking Alpha
Mon, 01/7/13 - 10:17 am
ALS
Lou Gehrig's disease
Biogen Idec
dexpramipexole
Biogen Sinks as ALS Drug Fails to Show Efficacy in Trial
Bloomberg
Thu, 01/3/13 - 11:36 am
ALS
Biogen Idec
dexpramipexole
Lou Gehrig's disease